Eye is the unique sense organ with complex and sophisticated anatomy and physiology.
Being most instrumental for vision, it is secured by varied protective barriers; ranging from …

Intraocular/Intravitreal implants constitute a relatively new method to treat eye diseases
successfully due to the possibility of releasing drugs in a controlled and prolonged way. This …

Purpose: To evaluate the efficacy, safety, and reinjection interval of dexamethasone
intravitreal implant (DEX implant) in branch retinal vein occlusion and central retinal vein …

Purpose: To assess the effect of dexamethasone (DEX) 0.7 mg (Ozurdex™) on refractory
and treatment-naïve diffuse diabetic macular edema. Methods: A prospective study was …

Vascular endothelial growth factor (VEGF) is a key regulator of abnormal blood vessel
growth. As such, bevacizumab-based inhibition of VEGF has been the clinically adopted …

Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical
industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the …

Purpose: To evaluate the effects of repeated intravitreal dexamethasone implant. Methods:
We reviewed the charts of 12 patients with diabetic macular edema, who received at least 2 …

Purpose The purpose of this study was to evaluate the safety and efficacy of dexamethasone
intravitreal implant 0.7 mg (DEX) for treatment of macular edema associated with retinal vein …

Purpose To compare the efficacy and safety of ranibizumab 0.5 mg versus dexamethasone
0.7 mg according to their European labels in macular oedema secondary to branch retinal …

Purpose To review the current practice of retreatment with Ozurdex injections in patients with
macular edema (ME) secondary to retinal vein occlusion (RVO), and to recommend simple …